|
2018-08-02 |
2018-07-31 |
A
Achat
|
ROCHE HOLDINGS INC
Administrateur non-exécutif
Actionnaire important
|
2 343 078
+6.8%
137,00
321 001 686 USD
|
2 343 078
+6.8%
|
137,00
|
321 001 686 USD
|
|
|
2018-08-02 |
2018-07-31 |
A
Achat
|
ROCHE HOLDINGS INC
Administrateur non-exécutif
Actionnaire important
|
13 877 949
+67.4%
137,00
1 901 279 013 USD
|
13 877 949
+67.4%
|
137,00
|
1 901 279 013 USD
|
|
|
2018-07-05 |
2018-07-02 |
V
Vente
|
Nallicheri Melanie
Chief Business Officer
Dirigeant
|
2 008
-3.0%
136,66
274 413 USD
|
2 008
-3.0%
|
136,66
|
274 413 USD
|
|
|
2018-07-05 |
2018-07-02 |
V
Vente
|
Ryan Jason
Chief Financial Officer
Dirigeant
|
3 403
-6.5%
136,66
465 054 USD
|
3 403
-6.5%
|
136,66
|
465 054 USD
|
|
|
2018-07-05 |
2018-07-02 |
V
Vente
|
Hesslein Robert W.
SVP and General Counsel
Dirigeant
|
2 520
-2.3%
136,66
344 383 USD
|
2 520
-2.3%
|
136,66
|
344 383 USD
|
|
|
2018-07-05 |
2018-07-02 |
V
Vente
|
Fiedler Konstantin
Chief Operating Officer
Dirigeant
|
994
-3.6%
136,66
135 840 USD
|
994
-3.6%
|
136,66
|
135 840 USD
|
|
|
2018-07-05 |
2018-07-02 |
V
Vente
|
Cox Troy
Chief Executive Officer
Administrateur exécutif
|
1 402
-0.6%
136,66
191 597 USD
|
1 402
-0.6%
|
136,66
|
191 597 USD
|
|
|
2018-07-05 |
2018-07-02 |
V
Vente
|
Miller Vincent A.
Chief Medical Officer
Dirigeant
|
2 909
-4.2%
136,66
397 544 USD
|
2 909
-4.2%
|
136,66
|
397 544 USD
|
|
|
2018-07-05 |
2018-07-02 |
V
Vente
|
Doherty Michael J
Head of Product Development
Dirigeant
|
2 675
-3.2%
136,66
365 566 USD
|
2 675
-3.2%
|
136,66
|
365 566 USD
|
|
|
2018-06-19 |
2018-06-15 |
VP
Vente planifiée
|
Pellini Michael J
Administrateur non-exécutif
|
3 500
-3.3%
105,45
369 075 USD
|
3 500
-3.3%
|
105,45
|
369 075 USD
|
|
|
2018-05-23 |
2018-05-21 |
VP
Vente planifiée
|
Miller Vincent A.
Chief Medical Officer
Dirigeant
|
1 570
-2.2%
85,00
133 450 USD
|
1 570
-2.2%
|
85,00
|
133 450 USD
|
|
|
2018-05-17 |
2018-05-16 |
VP
Vente planifiée
|
Cox Troy
Chief Executive Officer
Administrateur exécutif
|
2 157
-0.9%
77,10
166 305 USD
|
2 157
-0.9%
|
77,10
|
166 305 USD
|
|
|
2018-05-17 |
2018-05-15 |
VP
Vente planifiée
|
Pellini Michael J
Administrateur non-exécutif
|
3 500
-3.2%
76,05
266 175 USD
|
3 500
-3.2%
|
76,05
|
266 175 USD
|
|
|
2018-05-09 |
2018-05-07 |
V
Vente
|
Cox Troy
Chief Executive Officer
Administrateur exécutif
|
7 063
-2.8%
70,01
494 481 USD
|
7 063
-2.8%
|
70,01
|
494 481 USD
|
|
|
2018-04-18 |
2018-04-16 |
VP
Vente planifiée
|
Ryan Jason
Chief Financial Officer
Dirigeant
|
3 449
-6.2%
74,30
256 261 USD
|
3 449
-6.2%
|
74,30
|
256 261 USD
|
|
|
2018-04-18 |
2018-04-16 |
VP
Vente planifiée
|
Miller Vincent A.
Chief Medical Officer
Dirigeant
|
3 283
-4.5%
74,02
243 008 USD
|
3 283
-4.5%
|
74,02
|
243 008 USD
|
|
|
2018-04-18 |
2018-04-16 |
VP
Vente planifiée
|
Pellini Michael J
Administrateur non-exécutif
|
3 500
-3.1%
74,65
261 275 USD
|
3 500
-3.1%
|
74,65
|
261 275 USD
|
|
|
2018-04-05 |
2018-04-03 |
V
Vente
|
Doherty Michael J
Head of Product Development
Dirigeant
|
2
-0.0%
72,40
145 USD
|
2
-0.0%
|
72,40
|
145 USD
|
|
|
2018-04-05 |
2018-04-03 |
V
Vente
|
Ryan Jason
Chief Financial Officer
Dirigeant
|
1
-0.0%
72,40
72 USD
|
1
-0.0%
|
72,40
|
72 USD
|
|
|
2018-04-05 |
2018-04-03 |
VP
Vente planifiée
|
Pellini Michael J
Administrateur non-exécutif
|
13 659
-10.7%
70,28
959 955 USD
|
13 659
-10.7%
|
70,28
|
959 955 USD
|
|
|
2018-04-03 |
2018-04-02 |
V
Vente
|
Fiedler Konstantin
Chief Operating Officer
Dirigeant
|
358
-1.3%
74,88
26 807 USD
|
358
-1.3%
|
74,88
|
26 807 USD
|
|
|
2018-04-03 |
2018-04-02 |
V
Vente
|
Miller Vincent A.
Chief Medical Officer
Dirigeant
|
2 529
-3.3%
74,86
189 321 USD
|
2 529
-3.3%
|
74,86
|
189 321 USD
|
|
|
2018-04-03 |
2018-04-02 |
V
Vente
|
Miller Vincent A.
Chief Medical Officer
Dirigeant
|
354
-0.5%
75,00
26 550 USD
|
354
-0.5%
|
75,00
|
26 550 USD
|
|
|
2018-04-03 |
2018-04-02 |
V
Vente
|
Ryan Jason
Chief Financial Officer
Dirigeant
|
3 030
-5.1%
74,87
226 856 USD
|
3 030
-5.1%
|
74,87
|
226 856 USD
|
|
|
2018-04-03 |
2018-04-02 |
VP
Vente planifiée
|
Ryan Jason
Chief Financial Officer
Dirigeant
|
3 109
-5.0%
77,55
241 103 USD
|
3 109
-5.0%
|
77,55
|
241 103 USD
|
|
|
2018-04-03 |
2018-04-02 |
V
Vente
|
Hesslein Robert W.
SVP and General Counsel
Dirigeant
|
1 585
-1.5%
74,88
118 685 USD
|
1 585
-1.5%
|
74,88
|
118 685 USD
|
|
|
2018-04-03 |
2018-04-02 |
V
Vente
|
Nallicheri Melanie
Chief Business Officer
Dirigeant
|
1 253
-1.8%
74,88
93 825 USD
|
1 253
-1.8%
|
74,88
|
93 825 USD
|
|
|
2018-04-03 |
2018-04-02 |
V
Vente
|
Doherty Michael J
Head of Product Development
Dirigeant
|
8 190
-8.9%
74,87
613 185 USD
|
8 190
-8.9%
|
74,87
|
613 185 USD
|
|
|
2018-03-19 |
2018-03-15 |
VP
Vente planifiée
|
Pellini Michael J
|
3 500
-2.7%
78,29
274 015 USD
|
3 500
-2.7%
|
78,29
|
274 015 USD
|
|
|
2018-03-19 |
2018-03-15 |
VP
Vente planifiée
|
Ryan Jason
Chief Financial Officer
|
7 853
-13.8%
78,26
614 576 USD
|
7 853
-13.8%
|
78,26
|
614 576 USD
|
|
|
2018-03-19 |
2018-03-15 |
VP
Vente planifiée
|
Ryan Jason
Chief Financial Officer
|
7 147
-12.7%
78,26
559 324 USD
|
7 147
-12.7%
|
78,26
|
559 324 USD
|
|
|
2018-03-12 |
2018-02-20 |
VP
Vente planifiée
|
Miller Vincent A.
Chief Medical Officer
|
10 000
-13.6%
85,00
850 000 USD
|
10 000
-13.6%
|
85,00
|
850 000 USD
|
|
|
2018-03-12 |
2018-02-20 |
VP
Vente planifiée
|
Miller Vincent A.
Chief Medical Officer
|
6 811
-8.5%
85,00
578 935 USD
|
6 811
-8.5%
|
85,00
|
578 935 USD
|
|
|
2018-02-22 |
2018-02-20 |
VP
Vente planifiée
|
Miller Vincent A.
Chief Medical Officer
Dirigeant
|
20 000
-21.4%
76,87
1 537 400 USD
|
20 000
-21.4%
|
76,87
|
1 537 400 USD
|
|
|
2018-02-22 |
2018-02-20 |
VP
Vente planifiée
|
Miller Vincent A.
Chief Medical Officer
Dirigeant
|
9 375
-9.1%
76,87
720 656 USD
|
9 375
-9.1%
|
76,87
|
720 656 USD
|
|
|
2018-02-22 |
2018-02-20 |
VP
Vente planifiée
|
Miller Vincent A.
Chief Medical Officer
Dirigeant
|
2 633
-2.7%
76,87
202 399 USD
|
2 633
-2.7%
|
76,87
|
202 399 USD
|
|
|
2018-02-20 |
2018-02-15 |
VP
Vente planifiée
|
Pellini Michael J
Administrateur non-exécutif
|
17 324
-11.7%
67,69
1 172 662 USD
|
17 324
-11.7%
|
67,69
|
1 172 662 USD
|
|
|
2018-02-20 |
2018-02-15 |
VP
Vente planifiée
|
Ryan Jason
Chief Financial Officer
Dirigeant
|
15 000
-23.4%
67,53
1 012 950 USD
|
15 000
-23.4%
|
67,53
|
1 012 950 USD
|
|
|
2018-02-20 |
2018-02-15 |
VP
Vente planifiée
|
Cox Troy
Chief Executive Officer
Administrateur exécutif
|
9 012
-4.0%
67,22
605 787 USD
|
9 012
-4.0%
|
67,22
|
605 787 USD
|
|
|
2018-02-15 |
2018-02-13 |
VP
Vente planifiée
|
Kafka Steven J.
President & COO
Dirigeant
|
29 791
-48.6%
61,55
1 833 636 USD
|
29 791
-48.6%
|
61,55
|
1 833 636 USD
|
|
|
2018-02-09 |
2018-02-07 |
V
Vente
|
Kafka Steven J.
President & COO
Dirigeant
|
23 064
-27.3%
70,13
1 617 478 USD
|
23 064
-27.3%
|
70,13
|
1 617 478 USD
|
|
|
2018-02-09 |
2018-02-07 |
V
Vente
|
Cox Troy
Chief Executive Officer
Administrateur exécutif
|
26 713
-10.6%
70,13
1 873 383 USD
|
26 713
-10.6%
|
70,13
|
1 873 383 USD
|
|
|
2018-01-31 |
2018-01-29 |
VP
Vente planifiée
|
Miller Vincent A.
Chief Medical Officer
Dirigeant
|
4 400
-4.5%
75,00
330 000 USD
|
4 400
-4.5%
|
75,00
|
330 000 USD
|
|
|
2018-01-24 |
2018-01-22 |
VP
Vente planifiée
|
Miller Vincent A.
Chief Medical Officer
Dirigeant
|
17 187
-15.6%
70,27
1 207 730 USD
|
17 187
-15.6%
|
70,27
|
1 207 730 USD
|
|
|
2018-01-18 |
2018-01-17 |
VP
Vente planifiée
|
Miller Vincent A.
Chief Medical Officer
Dirigeant
|
5 534
-5.6%
65,39
361 868 USD
|
5 534
-5.6%
|
65,39
|
361 868 USD
|
|
|
2018-01-18 |
2018-01-17 |
VP
Vente planifiée
|
Pellini Michael J
Administrateur non-exécutif
|
10 150
-6.4%
65,52
665 028 USD
|
10 150
-6.4%
|
65,52
|
665 028 USD
|
|
|
2018-01-18 |
2018-01-16 |
VP
Vente planifiée
|
Miller Vincent A.
Chief Medical Officer
Dirigeant
|
5 408
-5.5%
65,26
352 926 USD
|
5 408
-5.5%
|
65,26
|
352 926 USD
|
|
|
2018-01-18 |
2018-01-16 |
VP
Vente planifiée
|
Miller Vincent A.
Chief Medical Officer
Dirigeant
|
3 813
-3.9%
65,26
248 836 USD
|
3 813
-3.9%
|
65,26
|
248 836 USD
|
|
|
2018-01-18 |
2018-01-16 |
VP
Vente planifiée
|
Hesslein Robert W.
SVP and General Counsel
Dirigeant
|
18 021
-15.5%
64,30
1 158 750 USD
|
18 021
-15.5%
|
64,30
|
1 158 750 USD
|
|
|
2018-01-18 |
2018-01-16 |
VP
Vente planifiée
|
Kafka Steven J.
President & COO
Dirigeant
|
4 148
-4.7%
65,71
272 565 USD
|
4 148
-4.7%
|
65,71
|
272 565 USD
|
|
|
2018-01-18 |
2018-01-16 |
VP
Vente planifiée
|
Ryan Jason
Chief Financial Officer
Dirigeant
|
20 000
-28.9%
64,38
1 287 600 USD
|
20 000
-28.9%
|
64,38
|
1 287 600 USD
|
|
|
2018-01-18 |
2018-01-16 |
VP
Vente planifiée
|
Ryan Jason
Chief Financial Officer
Dirigeant
|
1 035
-2.1%
64,38
66 633 USD
|
1 035
-2.1%
|
64,38
|
66 633 USD
|
|
|
2018-01-18 |
2018-01-16 |
VP
Vente planifiée
|
Pellini Michael J
Administrateur non-exécutif
|
27 138
-14.6%
64,19
1 741 988 USD
|
27 138
-14.6%
|
64,19
|
1 741 988 USD
|
|
|
2018-01-03 |
2018-01-03 |
V
Vente
|
Kafka Steven J.
President & COO
Dirigeant
|
2 257
-2.5%
64,00
144 448 USD
|
2 257
-2.5%
|
64,00
|
144 448 USD
|
|
|
2018-01-03 |
2018-01-02 |
V
Vente
|
Hesslein Robert W.
SVP and General Counsel
Dirigeant
|
472
-0.4%
64,00
30 208 USD
|
472
-0.4%
|
64,00
|
30 208 USD
|
|
|
2018-01-03 |
2018-01-02 |
V
Vente
|
Hesslein Robert W.
SVP and General Counsel
Dirigeant
|
1 392
-1.2%
64,00
89 088 USD
|
1 392
-1.2%
|
64,00
|
89 088 USD
|
|
|
2018-01-03 |
2018-01-02 |
V
Vente
|
Nallicheri Melanie
Chief Business Officer
Dirigeant
|
1 494
-2.5%
64,00
95 616 USD
|
1 494
-2.5%
|
64,00
|
95 616 USD
|
|
|
2018-01-03 |
2018-01-02 |
V
Vente
|
Ryan Jason
Chief Financial Officer
Dirigeant
|
944
-1.8%
64,00
60 416 USD
|
944
-1.8%
|
64,00
|
60 416 USD
|
|
|
2018-01-03 |
2018-01-02 |
V
Vente
|
Ryan Jason
Chief Financial Officer
Dirigeant
|
1 392
-2.6%
64,00
89 088 USD
|
1 392
-2.6%
|
64,00
|
89 088 USD
|
|
|
2018-01-03 |
2018-01-02 |
V
Vente
|
Kafka Steven J.
President & COO
Dirigeant
|
157
-0.2%
64,00
10 048 USD
|
157
-0.2%
|
64,00
|
10 048 USD
|
|
|
2018-01-03 |
2018-01-02 |
V
Vente
|
Miller Vincent A.
Chief Medical Officer
Dirigeant
|
709
-0.7%
64,00
45 376 USD
|
709
-0.7%
|
64,00
|
45 376 USD
|
|
|
2018-01-03 |
2018-01-02 |
V
Vente
|
Miller Vincent A.
Chief Medical Officer
Dirigeant
|
1 248
-1.3%
64,00
79 872 USD
|
1 248
-1.3%
|
64,00
|
79 872 USD
|
|
|
2018-01-03 |
2018-01-02 |
V
Vente
|
Miller Vincent A.
Chief Medical Officer
Dirigeant
|
392
-0.4%
64,00
25 088 USD
|
392
-0.4%
|
64,00
|
25 088 USD
|
|
|
2017-12-15 |
2017-12-13 |
V
Vente
|
JONES EVAN/ FA
|
1 400
-7.3%
62,05
86 870 USD
|
1 400
-7.3%
|
62,05
|
86 870 USD
|
|
|
2017-12-15 |
2017-12-13 |
V
Vente
|
Pellini Michael J
|
48 746
-20.8%
61,71
3 008 116 USD
|
48 746
-20.8%
|
61,71
|
3 008 116 USD
|
|
|
2017-12-11 |
2017-12-07 |
V
Vente
|
Kafka Steven J.
President & COO
|
50 896
-35.9%
61,66
3 138 247 USD
|
50 896
-35.9%
|
61,66
|
3 138 247 USD
|
|
|
2017-12-11 |
2017-12-07 |
V
Vente
|
Kafka Steven J.
President & COO
|
747
-0.8%
61,66
46 060 USD
|
747
-0.8%
|
61,66
|
46 060 USD
|
|
|
2017-12-11 |
2017-12-07 |
V
Vente
|
Kafka Steven J.
President & COO
|
35 156
-27.9%
61,66
2 167 719 USD
|
35 156
-27.9%
|
61,66
|
2 167 719 USD
|
|
|
2017-12-11 |
2017-12-07 |
V
Vente
|
Kafka Steven J.
President & COO
|
1 562
-1.7%
61,66
96 313 USD
|
1 562
-1.7%
|
61,66
|
96 313 USD
|
|
|
2017-12-07 |
2017-12-06 |
V
Vente
|
Kafka Steven J.
President & COO
|
5 774
-6.0%
58,57
338 183 USD
|
5 774
-6.0%
|
58,57
|
338 183 USD
|
|
|
2017-12-07 |
2017-12-06 |
V
Vente
|
Pellini Michael J
|
20 947
-8.1%
58,11
1 217 230 USD
|
20 947
-8.1%
|
58,11
|
1 217 230 USD
|
|
|
2017-12-07 |
2017-12-06 |
V
Vente
|
JONES EVAN/ FA
|
600
-3.1%
57,88
34 728 USD
|
600
-3.1%
|
57,88
|
34 728 USD
|
|
|
2017-12-07 |
2017-12-05 |
V
Vente
|
Ryan Jason
Chief Financial Officer
|
18 688
-26.2%
61,26
1 144 827 USD
|
18 688
-26.2%
|
61,26
|
1 144 827 USD
|
|
|
2017-12-07 |
2017-12-05 |
V
Vente
|
Ryan Jason
Chief Financial Officer
|
3 038
-5.5%
61,26
186 108 USD
|
3 038
-5.5%
|
61,26
|
186 108 USD
|
|
|
2017-12-07 |
2017-12-05 |
V
Vente
|
Pellini Michael J
|
9 053
-3.4%
61,47
556 488 USD
|
9 053
-3.4%
|
61,47
|
556 488 USD
|
|
